| Outline |
Indent Level
| |
| Color | Curly Brackets (indicating CPC extensions to IPC) | |
CPC | COOPERATIVE PATENT CLASSIFICATION | |||||||||||
![]() | FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE ( brewing of beer C12C ; producing vinegar C12J ; producing specific peptides or proteins C07K ; producing enzymes C12N 9/00 ; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N 15/00 ; measuring or testing processes involving enzymes or micro-organisms C12Q ; measuring or testing processes involving nucleic acid amplification reactions C12Q 1/6844 ; fermentation processes to form a food composition, A21 or A23 ; compounds in general, see the relevant compound class, e.g. C01 , C07 ) ] NOTE -
WARNING -
|
![]() | Preparation of compounds or compositions, not provided for in groups C12P 3/00 to C12P 39/00 , by using micro-organisms or enzymes NOTE -
|
C12P 3/00 | Preparation of elements or inorganic compounds except carbon dioxide { ( Recovery of carbon dioxides as by-products C12F 3/02 ) } |
![]() | Preparation of hydrocarbons { or halogenated hydrocarbons } |
![]() | Preparation of oxygen-containing organic compounds |
![]() | C12P 7/02 | . | containing a hydroxy group |
![]() | C12P 7/04 | . . | acyclic |
![]() | C12P 7/06 | . . . | Ethanol, i.e. non-beverage |
C12P 7/065 | . . . . | { with micro-organisms other than yeasts } |
![]() | C12P 7/08 | . . . . | produced as by-product or from waste or cellulosic material substrate |
C12P 7/10 | . . . . . | substrate containing cellulosic material |
C12P 7/12 | . . . . . | substrate containing sulfite waste liquor or citrus waste |
C12P 7/14 | . . . . | Multiple stages of fermentation ; Multiple types of micro-organisms or re-use of micro-organisms |
C12P 7/16 | . . . | Butanols |
![]() | C12P 7/18 | . . . | polyhydric |
C12P 7/22 | . . | aromatic |
![]() | C12P 7/24 | . | containing a carbonyl group |
![]() | C12P 7/26 | . . | Ketones |
![]() | C12P 7/28 | . . . | Acetone-containing products |
C12P 7/30 | . . . . | produced from substrate containing inorganic compounds other than water |
C12P 7/32 | . . . . | produced from substrate containing inorganic nitrogen source |
C12P 7/34 | . . . . | produced from substrate containing protein as nitrogen source |
C12P 7/36 | . . . . | produced from substrate containing grain or cereal material |
C12P 7/38 | . . . | Cyclopentanone- or cyclopentadione-containing products |
![]() | C12P 7/40 | . |
C12P 7/42 | . . | Hydroxy-carboxylic acids |
![]() | C12P 7/44 | . . | Polycarboxylic acids |
C12P 7/46 | . . . | Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid |
C12P 7/48 | . . . | Tricarboxylic acids, e.g. citric acid |
C12P 7/50 | . . . | having keto groups, e.g. 2-ketoglutaric acid |
C12P 7/52 | . . | Propionic acid ; Butyric acids |
C12P 7/54 | . . | Acetic acid ( vinegar C12J ) |
C12P 7/56 | . . | Lactic acid |
![]() | C12P 7/58 | . . | Aldonic, keto-aldonic or saccharic acids ( uronic acids C12P 19/00 ) |
![]() | C12P 7/62 | . |
![]() | . | Fats ; Fatty oils ; Ester-type waxes ; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group ; Oxidised oils or fats |
![]() | C12P 7/6409 | . . | { Fatty acids } |
C12P 7/6418 | . . . | { by hydrolysis of Fatty acid esters } |
C12P 7/6427 | . . . | { Polyunsaturated fatty acids (PUFA), i.e. having 2 or more double bonds in their backbone } |
![]() | C12P 7/6436 | . . | { Fatty acid esters } |
![]() | C12P 7/6445 | . . . | { Glycerides } |
C12P 7/6454 | . . . . | { by esterification } |
C12P 7/6463 | . . . . | { obtained from glyceride producing microorganisms, e.g. single cell oil } |
C12P 7/6472 | . . . . | { containing polyunsaturated fatty acid (PUFA) residues, i.e. having 2 or more double bonds in their backbone } |
C12P 7/6481 | . . . . | { Phosphoglycerides ( phosphoglycerides having carboxylic acids with less than 7 carbon atoms, C12P 7/62 ) } |
C12P 7/649 | . . . | { Biodiesel, i.e. Fatty acid alkyl esters } |
C12P 7/66 | . | containing the quinoid structure |
C12P 9/00 | Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen { ( phosphoglycerides, C12P 7/6481 ) } |
C12P 11/00 | Preparation of sulfur-containing organic compounds |
![]() | Preparation of nitrogen-containing organic compounds |
C12P 13/001 | . | { Amines; Imines } |
![]() | C12P 13/002 | . | { Nitriles (-CN) } |
C12P 13/005 | . | { Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids } |
C12P 13/007 | . | { Carnitine; Butyrobetaine; Crotonobetaine } |
C12P 13/008 | . | { containing a N-O bond, e.g. nitro (-NO2), nitroso (-NO) } |
C12P 13/02 | . | Amides, e.g. chloramphenicol { or polyamides; Imides or polyimides; Urethanes , i.e. compounds comprising N-C=O structural element or polyurethanes ( peptides C12P21 or C07K ) } |
![]() | C12P 13/04 | . |
C12P 13/06 | . . | Alanine ; Leucine ; Isoleucine ; Serine ; Homoserine |
C12P 13/08 | . . | Lysine ; Diaminopimelic acid ; Threonine ; Valine |
C12P 13/10 | . . | Citrulline ; Arginine ; Ornithine |
C12P 13/12 | . . | Methionine ; Cysteine ; Cystine |
![]() | C12P 13/14 | . . | Glutamic acid ; Glutamine |
C12P 13/16 | . . . | using surfactants, fatty acids or fatty acid esters, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group or a carboxyl ester group |
C12P 13/18 | . . . | using biotin or its derivatives |
C12P 13/20 | . . | Aspartic acid ; Asparagine |
![]() | C12P 13/22 | . . | Tryptophan ; Tyrosine ; Phenylalanine ; 3,4-Dihydroxyphenylalanine NOTE -
|
C12P 13/222 | . . . | { Phenylalanine } |
C12P 13/225 | . . . | { Tyrosine; 3,4-Dihydroxyphenylalanine } |
C12P 13/227 | . . . | { Tryptophan } |
C12P 13/24 | . . | Proline ; Hydroxyproline ; Histidine |
C12P 15/00 | Preparation of compounds containing at least three condensed carbocyclic rings { Gibbanes C12P 27/00 ; naphthacenes C12P 29/00 } |
![]() | Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms ( C12P 13/04 to C12P 13/24 take precedence ) |
![]() | C12P 17/02 | . | Oxygen as only ring hetero atom |
C12P 17/04 | . . | containing a five-membered hetero ring, e.g. griseofulvin, { vitamin C } |
C12P 17/06 | . . | containing a six-membered hetero ring, e.g. fluorescein |
C12P 17/08 | . . | containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons |
![]() | C12P 17/10 | . | Nitrogen as only ring hetero atom |
C12P 17/14 | . | Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring |
![]() | C12P 17/16 | . | containing two or more hetero rings { Thiamine open chain analogs C12P 17/167 ; i.e. not condensed among themselves or through a common carbocyclic ring system } |
C12P 17/162 | . . | { Heterorings having oxygen atoms as the only ring heteroatoms e.g. Lasalocid } |
C12P 17/165 | . . | { Heterorings having nitrogen atoms as the only ring heteroatoms } |
C12P 17/167 | . . | { Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs } |
![]() | C12P 17/18 | . | containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin, { e.g. Rifamycin C12P 17/189 } |
C12P 17/181 | . . | { Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin } |
![]() | C12P 17/182 | . . | { Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system ( Alloxazine or isoalloxazine, e.g. riboflavine C12P 25/00 ) } |
C12P 17/183 | . . . | { containing an indolo[4,3-F,G]quinoleine nucleus, e.g. compound containing the lysergic acid nucleus as well as the dimeric ergot nucleus } |
C12P 17/184 | . . . | { containing a beta-lactam ring, e.g. thienamycin } |
![]() | C12P 17/185 | . . | { Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system } { cepam nucleus C12P 35/00 ; penam nucleus C12P 37/00 } |
C12P 17/186 | . . . | { containing a 2-oxo-thieno[3,4-d]imidazol nucleus, e.g. Biotin } |
C12P 17/187 | . . . | { containing two or more directly linked sulfur atoms, e.g. epithiopiperazines } |
![]() | C12P 17/188 | . . | { Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms ( ergot-alcaloids C12P 17/183 ) } |
![]() |
C12P 19/02 | . | Monosaccharides ( 2-ketogulonic acid C12P 7/60 ) |
![]() | C12P 19/04 | . | Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds |
C12P 19/06 | . . | Xanthan, i.e. Xanthomonas-type heteropolysaccharides |
C12P 19/08 | . . | Dextran |
C12P 19/10 | . . | Pullulan |
C12P 19/12 | . | Disaccharides |
C12P 19/14 | . | produced by the action of a carbohydrase { ( EC 3.2.x ) } , e.g. by alpha-amylase, { e.g. by cellulase, hemicellulase } |
C12P 19/16 | . | produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin ( non-biological hydrolysis of starch C08B 30/00 ) |
C12P 19/18 | . | produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins |
C12P 19/20 | . | produced by the action of an exo-1,4 alpha-glucosidase, e.g. dextrose |
C12P 19/22 | . | produced by the action of a beta-amylase, e.g. maltose |
C12P 19/24 | . | produced by the action of an isomerase, e.g. fructose |
![]() | C12P 19/26 | . | Preparation of nitrogen-containing carbohydrates |
![]() | C12P 19/28 | . . | N-glycosides |
![]() | C12P 19/30 | . . . | Nucleotides |
C12P 19/305 | . . . . | { Pyrimidine nucleotides } |
C12P 19/32 | . . . . | having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide |
C12P 19/34 | . . . . | Polynucleotides, e.g. nucleic acids, oligoribonucleotides |
C12P 19/36 | . . . . | Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate |
![]() | C12P 19/38 | . . . | Nucleosides |
C12P 19/385 | . . . . | { Pyrimidine nucleosides } |
C12P 19/40 | . . . . | having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides |
C12P 19/42 | . . . | Cobalamins, i.e. vitamin B12, LLD factor |
![]() | C12P 19/44 | . | Preparation of O-glycosides, e.g. glucosides { Polysaccharides and not substituted disaccharides C12P 19/04 , C12P 19/12 } |
C12P 19/445 | . . | { The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin } |
![]() | C12P 19/46 | . . | having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin |
![]() | C12P 19/48 | . . . | the cyclohexyl radical being substituted by two or more nitrogen atoms, e.g. destomycin, neamin |
C12P 19/485 | . . . . | { Having two saccharide radicals bound through only oxygen to non-adjacent ring carbons of the cyclohexyl radical, e.g. gentamycin, kanamycin, sisomycin, verdamycin, mutamycin, tobramycin, nebramycin, antibiotics 66-40B, 66-40D, XK-62-2, 66-40, G-418, G-52 ( see also C12P 19/54 ) } |
![]() | C12P 19/50 | . . . . | having two saccharide radicals bound through only oxygen to adjacent ring carbon atoms of the cyclohexyl radical, e.g. ambutyrosin, ribostamycin |
C12P 19/54 | . . . | the cyclohexyl radical being bound directly to a nitrogen atom of two or more radicals, e.g. streptomycin |
C12P 19/56 | . . | having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin |
C12P 19/58 | . . | having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide hetero-cyclic ring, e.g. bleomycin, phleomycin |
![]() | C12P 19/60 | . . | having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin { C12P 19/605 } |
C12P 19/64 | . | Preparation of S-glycosides, e.g. lincomycin |
![]() | Preparation of peptides or proteins ( single cell protein C12N 1/00 ) |
C12P 21/005 | . | { Glycopeptides, glycoproteins } |
C12P 21/02 | . | having a known sequence of two or more amino acids, e.g. glutathione |
C12P 21/06 | . | produced by the hydrolysis of a peptide bond, e.g. hydrolysate products ( preparing foodstuffs by protein hydrolysis A23J 3/00 ) |
C12P 23/00 | Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes ( containing heterorings C12P 17/00 ) |
C12P 25/00 | Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin |
C12P 27/00 | Preparation of compounds containing a gibbane ring system, e.g. gibberellin |
C12P 29/00 | Preparation of compounds containing a naphthacene ring system, e.g. tetracycline ( C12P 19/00 takes precedence ) |
C12P 31/005 | . | { by fermentation or enzyme-using processes from marine organisms, e.g. Plexaura Homomalla } |
![]() | Preparation of steroids NOTE -
|
C12P 33/005 | . | { Degradation of the lateral chains at position 17 } |
![]() | C12P 33/02 | . | Dehydrogenating ; Dehydroxylating |
![]() | C12P 33/06 | . | Hydroxylating |
![]() | C12P 33/12 | . | Acting on D ring { carbons 13 and 14 belong to the C ring; degradation of lateral chains C12P 33/005 } |
C12P 33/20 | . |
![]() | Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin |
C12P 35/02 | . | by desacylation of the substituent in the 7 position |
C12P 35/04 | . | by acylation of the substituent in the 7 position |
C12P 35/06 | . | Cephalosporin C ; Derivatives thereof |
C12P 35/08 | . | disubstituted in the 7 position |
![]() | Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin |
C12P 37/02 | . | in presence of phenylacetic acid or phenylacetamide or their derivatives { not to be used } |
C12P 37/04 | . | by acylation of the substituent in the 6 position |
C12P 37/06 | . | by desacylation of the substituent in the 6 position |
C12P 39/00 | Processes involving micro-organisms of different genera in the same process, simultaneously |
![]() | Processes using enzymes or micro-organisms to separate optical isomers from a racemic mixture |
C12P 41/001 | . | { by metabolizing one of the enantiomers } |
C12P 41/002 | . | { by oxidation/reduction reactions } |
![]() | C12P 41/003 | . | { by ester formation, lactone formation or the inverse reactions } |
C12P 41/004 | . . | { by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction } |
C12P 41/005 | . . | { by esterification of carboxylic acid groups in the enantiomers or the inverse reaction } |
![]() | C12P 41/006 | . | { by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures } |
C12P 2201/00 | Pretreatment of cellulosic or lignocellulosic material for subsequent enzymatic treatment or hydrolysis |
C12P 2203/00 | Fermentation products obtained from optionally pretreated or hydrolyzed cellulosic or lignocellulosic material as the carbon source ( ethanol C12P 7/10 ) |